EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Multifaceted Therapeutic Impacts of Cucurbitacin B: Recent Evidences From Preclinical Studies

Meenal Sahu, Tripti Paliwal, Smita Jain, Kanika Verma, Dipjyoti Chakraborty, Shivangi Jaiswal, Jaya Dwivedi iD, Swapnil Sharma iD

Phytotherapy Research · 2025-05 · 39 (5) · 1966-1995

DOI: 10.1002/ptr.8454 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Phytotherapy Research, online erschienen am 18.02.2025. Verfasst von Meenal Sahu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioscience & Biotechnology, Banasthali Vidyapith, Banasthali, Rajasthan, India. Hauptthemen laut MEDLINE: Triterpenes. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 161 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The most prevalent and bioactive cucurbitacin is Cucurbitacin B (CuB, C 32 H 46 O 8 ), which is a tetracyclic triterpene chiefly present in the Cucurbitaceae family. CuB has a wide spectrum of pharmacological properties namely antioxidant, anticancer, hepatoprotective, anti‐inflammatory, antiviral, hypoglycaemic, insecticidal, and neuroprotective properties, owing to its ability to regulate several signaling pathways, including the Janus kinase/signal transducer and activator of transcription‐3 (JAK/STAT3), AMP‐activated protein kinase (AMPK), nuclear factor (NF)‐κB, nuclear factor erythroid 2‐related factor‐2/antioxidant responsive element (Nrf2/ARE), phosphoinositide 3‐kinase (PI3K)/Akt, mitogen‐activated protein kinase (MAPK), Hippo‐Yes‐associated protein (YAP), focal adhesion kinase (FAK), cancerous inhibitor of protein phosphatase‐2A/protein phosphatase‐2A (CIP2A/PP2A), Wnt and Notch pathways. The present review highlights the medicinal attributes of Cucurbitacin B (CuB) with special emphasis on their signaling pathways to provide key evidence of its therapeutic utility in the near future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TriterpenesHumansAnimalsSignal Transduction

Stichwörter der Autor:innen

Cucumis callosusCucurbitacin Bpharmacologysignalingtoxicity

Substanzen

Triterpenescucurbitacin B

Autor:innen und Institutionen

  • Department of Bioscience & Biotechnology, Banasthali Vidyapith, Banasthali, Rajasthan, India.
  • Department of Pharmacy, Banasthali Vidyapith, Banasthali, Rajasthan, India.
  • Department of Pharmacy, School of Chemical Sciences and Pharmacy, Central University of Rajasthan, Kishangarh, Rajasthan, India.
  • Department of Internal Medicine, Division of Cardiology, LSU Health Sciences Center, Shreveport, Louisiana, USA.
  • Department of Chemistry, Banasthali Vidyapith, Banasthali, Rajasthan, India.

ORCID-Profile: Jaya Dwivedi, Swapnil Sharma

Zitieren

APA

Sahu, M., Paliwal, T., Jain, S., Verma, K., Chakraborty, D., Jaiswal, S., Dwivedi, J., & Sharma, S. (2025). Multifaceted Therapeutic Impacts of Cucurbitacin B: Recent Evidences From Preclinical Studies. Phytotherapy Research, 39(5), 1966-1995. https://doi.org/10.1002/ptr.8454

Vancouver

Sahu M, Paliwal T, Jain S, Verma K, Chakraborty D, Jaiswal S, et al. Multifaceted Therapeutic Impacts of Cucurbitacin B: Recent Evidences From Preclinical Studies. Phytotherapy Research. 2025;39(5):1966-1995. doi:10.1002/ptr.8454

BibTeX
@article{Sahu2025,
  author = {Sahu, Meenal and Paliwal, Tripti and Jain, Smita and Verma, Kanika and Chakraborty, Dipjyoti and Jaiswal, Shivangi and Dwivedi, Jaya and Sharma, Swapnil},
  title = {Multifaceted Therapeutic Impacts of Cucurbitacin B: Recent Evidences From Preclinical Studies},
  journal = {Phytotherapy Research},
  year = {2025},
  volume = {39},
  number = {5},
  pages = {1966--1995},
  doi = {10.1002/ptr.8454}
}
Kostenlos starten →